Pre-Annual General Meeting Information • Jun 2, 2016
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
Villers-lès-Nancy, June02, 2016 – 18h30 (CET)
The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary General Meeting that will be held on Thursday, June 23, 2016 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
The Preliminary Notice of Meeting, including the agenda, the draft resolutions the Board of Directors submits to the vote of the shareholders, as well as information concerning the Shareholders' Meeting attendance and voting procedures, was published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 16, 2016.
Pursuant to article R. 225-73-1 of the French commercial code, the Meeting Materials as well as the form of proxy are available on the company's web site : www.pharmagest.com, Investor Relations, since June 2, 2016.
A convening notice to attend the meeting will be published on June 6, 2016 in the BALO, in the Official Journal "Tablettes Lorraines" and on the company's website.
The PHARMAGEST Group is the French leader in pharmacy information technology, with a 43.5% share of the market and over 800 employees. The strategy of the PHARMAGEST Group is based on a core business – innovating in information technology to improve healthcare – and on the development of two priority focuses: services and technologies for healthcare professionals, notably support for pharmacists in monitoring patient compliance; and technology for improving the efficacy of healthcare systems.
To roll out that strategy, the PHARMAGEST Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for laboratories, connected health devices and apps, and a sales financing marketplace.
These businesses are divided into 4 Divisions: the Solutions for Pharmacy Division – Europe, the Solutions for Sanitary and Medico-Social Establishments Division, the Solutions for e-Health Division, and the FinTech Division.
Listed on Euronext Paris™ - Compartment B Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion Eligible for the Long-Only Deferred Settlement Service (SRD) ISIN: FR0012882389 – Reuters: PHA.PA – Bloomberg: PMGI FP PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)
For all the latest news, go to www.pharmagest.com
Analyst and Investor Relations: Chief Financial Officer: Jean-Yves SAMSON Tel. +33 (0)3 83 15 90 67 – [email protected]
Press Relations: FIN'EXTENSO – Isabelle APRILE Tel. +33 (0)1 39 97 61 22 - [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.